If you have been reading about copper(II) complex and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-06-07. Numbers and descriptions here follow the published literature rather than marketing material.
The copper-binding activity of this sequence was described in the 1970s during studies of liver tissue and plasma factors. Early work identified the peptide as a component that influenced copper uptake by cells and that appeared in wound fluid. Later investigations examined its presence across species, reporting the same chain in human and animal samples. A decline in measured concentration with age became a recurring observation, although the underlying causes remain incompletely characterised.
Published studies describe the complex in several research contexts, including collagen synthesis, antioxidant behaviour, and wound repair models. Much of this work is conducted in cultured cells or in small animal systems, and the findings are frequently cited in reviews of copper peptides. Direct clinical evidence in humans is comparatively limited, and reported outcomes vary with formulation and study design. Whether free chain or metal-bound form was used is not always stated, a point that complicates comparison between reports.
GHK-Cu is a coordination complex formed between the peptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The unbound chain, abbreviated GHK, consists of three amino acids and occurs naturally in human plasma, saliva, and urine. Binding of the metal is mediated mainly by the imidazole nitrogen of the histidine residue together with backbone amides, producing a stable chelate. Ingredient nomenclature often lists the same substance as copper tripeptide-1. Its charge and solubility behaviour differ from those of the metal-free chain.
Mechanistic accounts focus on how the complex delivers copper and how the released peptide interacts with the extracellular matrix. Copper is an essential cofactor for lysyl oxidase and other enzymes involved in collagen and elastin cross-linking, and GHK is one of several peptides able to carry the metal. Reported effects include altered gene expression in fibroblasts and changes in matrix metalloproteinase activity, although many of these findings come from cell culture rather than whole organisms. The relative contribution of the peptide backbone, the copper ion, and downstream copper metabolism is not fully resolved.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.
The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Copper(II) peptide complex | Coordination compound rather than a simple salt |
| Peptide sequence | Glycyl-L-histidyl-L-lysine | Abbreviated GHK in most literature |
| Molecular formula | C14H22N6O4Cu | Reported for the 1:1 complex |
| Principal binding site | Histidine imidazole nitrogen | Backbone amides contribute additional coordination |
| Common synonym | Copper tripeptide-1 | Used in ingredient and product labelling |
Research interest in GHK-Cu centers on its ability to deliver copper and to influence cellular processes in laboratory models. In cell culture and animal studies, the complex has been linked to collagen synthesis, antioxidant enzyme activity, and expression of genes associated with tissue remodeling. These effects are not equivalent to proven clinical outcomes. The mechanisms proposed include copper transfer to cuproenzymes, modulation of growth factor signaling, and interactions with extracellular matrix components. How much of the observed activity depends on intact GHK-Cu versus free copper or free peptide is not fully resolved.
The compound entered scientific literature in the 1970s, when plasma factors with copper-binding activity were isolated and characterized. Later work expanded into wound healing, skin biology, and cosmetic formulation, where copper tripeptide-1 became a recognized ingredient name. Most published studies remain preclinical or small-scale, and findings are often reported in specialized dermatology or peptide journals. Regulatory treatment varies: some jurisdictions allow it as a cosmetic ingredient, while research-grade material is sold for laboratory use. Questions about optimal delivery, target tissues, and long-term effects continue to be investigated rather than settled.
Commercial products list GHK-Cu as copper tripeptide-1, a cosmetic ingredient. Formulators value its blue color and water solubility, which allow incorporation into serums, creams, and masks. Regulatory treatment varies: in the United States it appears in cosmetics, while some jurisdictions classify certain claims as drug-like. The compound is not an approved drug for any indication. Studies continue to examine its effects on skin, hair, and wound repair, but dosage, delivery, and long-term safety questions remain open.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and copper(II). The peptide sequence consists of glycine, histidine, and lysine, and its imidazole and amino groups provide binding sites for the metal ion. In the complex, copper is held through nitrogen donors from the histidine side chain, the N-terminal amine, and deprotonated amide nitrogens. The resulting compound is intensely blue and water-soluble. It occurs naturally in human plasma, saliva, and urine at low concentrations.
Copper binds to the peptide through the histidine imidazole nitrogen and the terminal amino group, forming a stable square-planar complex. Binding constants reported for copper(II) with GHK are high, so the peptide competes effectively for copper in solution. The complex absorbs visible light, which gives solutions a blue to violet colour. Whether the metal-free peptide has a distinct biological function of its own is still an open question; some work treats it mainly as a copper delivery vehicle, while other work reports peptide-specific effects.
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
Hyperandrogenism is a medical condition characterized by high levels of androgens. It is more common in women than men. Symptoms of hyperandrogenism may include acne, seborrhea, hair loss on the scalp, increased body or facial hair, and infrequent or absent menstruation. Complications may include high blood cholesterol and diabetes. It occurs in approximately 5% of women of reproductive age. Polyendocrine metabolic ovarian syndrome accounts for about 70% of hyperandrogenism cases. Other causes include Congenital adrenal hyperplasia, insulin resistance, hyperprolactinemia, Cushing's disease, certain types of cancers, and certain medications. Diagnosis often involves blood tests for testosterone, 17-hydroxyprogesterone, and prolactin, as well as a pelvic ultrasound. Treatment depends on the underlying cause. Symptoms of hyperandrogenism can be treated with birth control pills or antiandrogens, such as cyproterone acetate or spironolactone. Other measures may include hair removal techniques. The earliest known description of the condition is attributed to Hippocrates. In 2011, the International Association of Athletics Federations (now World Athletics) and IOC (International Olympic Committee) released statements restricting the eligibility of female athletes with high testosterone, whether through hyperandrogenism or as a result of a difference in sex development (DSD). These regulations were referred to by both bodies as hyperandrogenism regulations and have led to athletes with DSDs being described as having hyperandrogenism.
=== Assisted children === The Paris Archives hold registers for the admission of foundlings, abandoned children, orphans, and rescued minors, referred to as “assisted children.” These records span from 1742 to 1924, with a gap between 1748 and 1754. Available online, they provide registration numbers that allow access to the admission files on-site.
Thus, glutathione acts unusually as a coenzyme and is required only in catalytic (i.e., very small) amounts; normally, glutathione acts instead as a redox couple in oxidation-reduction reactions. The glyoxalase system has also been suggested to play a role in regulating cell growth and in assembling microtubules.
Cisplatin and derivatives include cisplatin, carboplatin and oxaliplatin. They impair cell function by forming covalent bonds with the amino, carboxyl, sulfhydryl, and phosphate groups in biologically important molecules. Non-classical alkylating agents include procarbazine and hexamethylmelamine.
(pH at which there is an equilibrium between its ionized and non-ionized molecules), it is possible to calculate the non-ionized concentration of the drug and therefore the concentration that will be subject to absorption:
Sources: en.wikipedia.org
In 2011, the American Society of Pharmacometrics (ASoP) was founded by a number of local American groups, and over 600 members worldwide joined ASoP within 6 months. In 2012, ASoP evolved to the International Society of Pharmacometrics (ISoP) to reflect the increasing number of international members. ISoP's growth continues and the society currently represents over 1000 members from almost 30 countries around the world.
== Bound-state β− decay == A very small minority of free neutron decays (about four per million) are "two-body decays": the proton, electron and antineutrino are produced, but the electron fails to gain the 13.6 eV energy necessary to escape the proton, and therefore simply remains bound to it, as a neutral hydrogen atom. In this type of beta decay, in essence all of the neutron decay energy is carried off by the antineutrino. For fully ionized atoms (bare nuclei), it is possible in likewise manner for electrons to fail to escape the atom, and to be emitted from the nucleus into low-lying atomic bound states (orbitals). This can in theory occur for neutral atoms, as a new bound state is always opened by the decay, but rarely is appreciable. Bound-state β− decays were predicted by Daudel, Jean, and Lecoin in 1947, and the phenomenon in fully ionized atoms was first observed for 163Dy66+ in 1992 by Jung et al. of the Darmstadt Heavy-Ion Research Center. Though neutral 163Dy is stable, fully ionized 163Dy66+ undergoes β− decay into the K and L shells with a half-life of 47 days. The resulting nucleus – 163Ho66+ – is stable only in this almost fully ionized state and will decay via electron capture back into 163Dy in the neutral state. Likewise, while being stable in the neutral state, the fully ionized 205Tl81+ undergoes bound-state β− decay to 205Pb81+ with a half-life of 291+33−27 days. The half-lives of neutral 163Ho and 205Pb are respectively 4570 years and 1.70×107 years. The Q-value of bound-state beta decay of a highly-ionized atom,
=== Casting === Bosworth was paid $500,000 to star as undercover cop Joe Huff, This was his first non-football role, and he trained extensively with acting coach Harold Guskin. Wichard, who was noted for his hyperbolic statements, claimed that some of the lessons lasted up to 20 hours. Michelle Johnson signed on to play Huff's wife, while Punky Brewster's Ami Foster was cast as his troubled younger sister, but creative changes led to both characters being cut during production. Lance Henriksen and Arabella Holzbog had appeared together shortly before in The Last Samurai. Henriksen had also co-starred with William Forsythe in the 1985 biker movie Savage Dawn. The lead actors trained with biker and stuntman Greg "Magic" Schwartz. Bosworth and Henriksen, both motorcycle enthusiasts, personally oversaw the customization of their bikes for the film. Henriksen's was painted by Jane Pollack, a member of the film's art department, who would later become his wife although the two did not connect on this shoot. Henriksen was unconvinced by the background players selected to portray his "Brotherhood", and personally toured Gulf Coast bike shops to recruit some that looked more legitimate. However, when a reporter mistakenly stated that Henriksen was a real-life member of the Bandidos MC gang, a rebuttal had to be quickly put out to avoid tensions with any of them.
== Medical uses == Rusfertide is indicated for the treatment of erythrocytosis in adults with polycythemia vera. Polycythemia vera ia a rare blood disorder that causes the body to make too many red blood cells. The excess cells can thicken the blood and increase the risk of cardiovascular issues, such as blood clots, stroke and heart attack.
Sources: en.wikipedia.org
On August 23, 1879, 26 members of the Christian Scientists' Association were granted a charter to form the Church of Christ (Scientist). Services were held in people's homes in Lynn and later in Hawthorne Hall, Boston. On January 31, 1881, Eddy was granted a charter to form the Massachusetts Metaphysical College to teach "pathology, ontology, therapeutics, moral science, metaphysics, and their application to the treatment of disease." The college lived wherever Eddy did; a new sign appeared on 8 Broad Street. In October 1881 there was a revolt. Eight church members resigned, signing a document complaining of Eddy's "frequent ebullitions of temper, love of money, and the appearance of hypocrisy." Only a few students remained, including Calvin Frye, who became Eddy's most loyal personal assistant. They appointed Eddy pastor of the church in November 1881, and drew up a resolution in February 1882 that she was "the chosen messenger of God to the nations." Despite the support, the resignations ended Eddy's time in Lynn. The church was struggling and her reputation had been damaged by the disputes. By now 61 years old, she decided to move to Boston, and in early 1882 rented a house at 569 Columbus Avenue, a silver plaque announcing the arrival of the Massachusetts Metaphysical College.
== Neurodegeneration == Motor neural degeneration is the progressive weakening of neural tissues and connections in the nervous system. Muscles begin to weaken as there are no longer any motor nerves or pathways that allows for muscle innervation. Motor neuron diseases can be viral, genetic or be a result of environmental factors. The exact causes remain unclear, however many experts believe that toxic and environmental factors play a large role.
Three-quarters of sickle cell cases occur in Africa. A World Health Organization report dated 2006 estimated that around 2% of newborns in Nigeria are affected by sickle cell anaemia, giving a total of 150,000 affected children born every year in Nigeria alone. The carrier frequency ranges between 10 and 40% across equatorial Africa, decreasing to 1–2% on the North African coast and <1% in South Africa. In the West African countries of Ghana and Nigeria, the frequencies can vary from 15 to 30%. In Nigeria, 24% of the population carries the gene, and 20 per 1,000 newborns are born with the disease, or 150,000 annually. Uganda has the fifth-highest sickle cell disease burden in Africa. One study indicates that 20,000 babies per year, or 0.7% of the total, are born with sickle cell disease, and 13.3% carry the trait. In Uganda, carrier frequency of the trait varies strongly across tribal lines: among the Baamba, it reaches 45%.
Simon (1973), art dealer and historian who discovered Da Vinci's Salvator Mundi Albie Hecht (1974), founder of Spike TV, head of HLN, and former president of Nickelodeon; creator of Nickelodeon Kids' Choice Awards; Academy Award-nominated producer Alan Goodman (1974), MTV founding executive and Nickelodeon executive Gara LaMarche (1976), former president and CEO of The Atlantic Philanthropies; president of advocacy group Democracy Alliance J. Ezra Merkin (1976), financier, hedge fund manager; former chairman of GMAC Inc. John Slosar (1978), chairman of Swire Pacific and Cathay Pacific airlines Daniel E. Straus (1978), founder of CareOne LLC and former vice chairman of Memphis Grizzlies Jeph Loeb (1979), television writer and EVP of Marvel Television, four-time Eisner Award winner Sami Mnaymneh (1981), billionaire, private equity executive, co-founder of H.I.G. Capital Charles Murphy (1981), hedge fund manager, executive of Fairfield Greenwich Group Tom Glocer (1981), former CEO of Thomson Reuters and Reuters Christopher Radko (1981), businessman and designer, founder of the eponymous Christmas ornaments company Donald F. Ferguson (1982), chief technology officer at Dell and professor of Professional Practice in Computer Science at Columbia University Wayne Allyn Root (1983), business mogul, TV personality and producer, author, 2008 Libertarian Party vice-presidential nominee Daniel S.
=== Reopening Chicago Public Schools === While SHIELD Illinois provided free SARS-CoV-2 testing to most school districts throughout Illinois and submitted a proposal to test Chicago Public Schools ("CPS"), CPS ultimately chose Massachusetts-based Thermo Fisher Scientific as its testing vendor. Despite this, when logistical issues related to the Omicron surge led to test result delays, 25,000 specimens rejected as invalid, and a vote by the Chicago Teachers Union ("CTU") to postpone the start of school in January 2022, SHIELD Illinois provided CPS with SHIELD's entire stockpile of over 300,000 rapid antigen tests. This allowed CPS to achieve testing levels at which CTU felt comfortable returning to the classroom and get the 340,000 students in CPS back into the classroom.
Sources: en.wikipedia.org
GHK denotes the unbound chain of three amino acids. GHK-Cu describes the form in which a copper(II) ion is held by that chain. The two are not interchangeable in solution, since charge, molecular weight, and reactivity differ.
The chain occurs in human plasma, saliva, and urine. Measured amounts are reported to fall with age. Copper binding by the sequence is treated as part of normal metal handling in tissue.
The bound copper(II) centre contributes to redox behaviour and to stability under physiological conditions. Free copper ions can participate in reactions that generate reactive species, while chelated metal is generally more controlled. The chain may also serve as a carrier for copper in experimental systems.
It is the copper(II) complex of the tripeptide glycyl-L-histidyl-lysine, a sequence of three amino acids. The copper ion is held by the histidine imidazole, the terminal amino group, and an amide nitrogen. The bound form is distinct from the free peptide in charge, color, and stability.